Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
Phase 2 Completed
24 enrolled
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Phase 2 Completed
75 enrolled 12 charts
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Phase 2 Completed
56 enrolled 13 charts
SAMCO
Phase 2 Completed
132 enrolled
OPTIPRIME
Phase 2 Completed
118 enrolled
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Phase 1/2 Completed
111 enrolled 22 charts
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Phase 2 Completed
16 enrolled 11 charts
SULTAN
Phase 2 Completed
20 enrolled
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer
Phase 1/2 Completed
29 enrolled 17 charts
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
Phase 1/2 Completed
177 enrolled 31 charts
Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab
Phase 2 Completed
74 enrolled 15 charts
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Phase 1/2 Completed
45 enrolled 12 charts
VALIDATE
Completed
647 enrolled
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Phase 2 Completed
200 enrolled 23 charts
PARADIGM
Phase 3 Completed
823 enrolled 20 charts
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
320 enrolled 13 charts
P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.
Phase 1/2 Completed
22 enrolled
VOLFI
Phase 2 Completed
93 enrolled
PanaMa
Phase 2 Completed
387 enrolled
Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer
Phase 1 Completed
14 enrolled 12 charts
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Phase 2 Completed
47 enrolled 13 charts
TRIPLETE
Phase 3 Completed
435 enrolled
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
Phase 2 Completed
285 enrolled 31 charts
Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients
Completed
213 enrolled 30 charts
Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
203 enrolled 14 charts
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Phase 3 Completed
463 enrolled 17 charts
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Phase 3 Completed
1,183 enrolled 18 charts
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Phase 2 Completed
52 enrolled 17 charts
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Phase 3 Completed
1,010 enrolled 22 charts
CHRONOS
Phase 2 Completed
32 enrolled
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
Phase 3 Completed
1,198 enrolled
A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer
Phase 2 Completed
14 enrolled
IMPROVE
Phase 2 Completed
151 enrolled
PIER
Phase 2 Completed
34 enrolled
S10PANI01
Phase 2 Completed
32 enrolled
GATTO
Phase 1 Completed
50 enrolled
OPALO
Phase 2 Completed
20 enrolled
Chemoradiation and Panitumumab for Esophageal Cancer
Phase 2 Completed
78 enrolled
CaboMAb
Phase 1 Completed
29 enrolled
MEGA
Phase 2 Completed
162 enrolled
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Phase 2 Completed
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Phase 2 Completed
35 enrolled 7 charts
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Phase 2 Completed
72 enrolled
Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer
Phase 2 Completed
154 enrolled 18 charts
SAPPHIRE
Phase 2 Completed
164 enrolled 29 charts
RAP
Phase 1 Completed
43 enrolled
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
Phase 2 Completed
11 enrolled
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
VECTITAX
Phase 2 Completed
40 enrolled
MetAction
Phase 2 Completed
50 enrolled